JD Supra2d
Federal Circuit Highlights the Importance of Separating Claim Construction and Infringement Analysis When Dealing with After-Arising Technology
Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc., No. 23-2218 (Fed. Cir. 2025) — On January 10, 2025, the Federal Circuit reversed ...
spectator.com.au6d
Revealed: GPs are over-diagnosing mental health conditions
Britain is turning sadness into sickness. More than four in five GPs believe that the ups and downs of normal life are being ...
Le Lézard3d
Ken Kendrick, Managing General Partner of the Arizona Diamondbacks, to Receive Prestigious 2025 Horatio Alger Award
Horatio Alger Association of Distinguished Americans, Inc., a nonprofit educational organization that honors the achievements of outstanding leaders who have overcome adversity and supports promising ...
New plan for DWP PIP shake-up would scrap payments for mental health claimants
The Department for Work and Pensions has been told it must restrict PIP to physical ailments and stop cash payments for ...
Business Wire1d
Kirin Holdings: Improving The Sustainability Of Black Tea Farms In Sri Lanka Through The Regenerative Tea Scorecard In Conjunction With The Rainforest Alliance
Kirin Holdings Company, Ltd. (Kirin Holdings) (TOKYO: 2503) and Kirin Beverage Company, Ltd. (Kirin Beverage) have been ...
JD Supra1d
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...
Le Lézard2d
Intelligent Automation Brings Enhanced Efficiency to European Enterprises, ISG Study Finds
The rise of generative AI (GenAI) and agentic process automation are driving demand for responsible AI frameworks and transforming how businesses in Europe operate, according to a new research report ...
Novartis's SWOT analysis: pharma giant's stock faces pipeline and pricing pressures
Novartis AG (NYSE:NVS), a global healthcare company valued at over $206 billion, has undergone significant transformation in recent years, focusing its efforts on becoming a pure-play pharmaceutical ...
Strong Q3, Improved Guidance Are Signs Takeda Pharmaceutical May Be Undervalued
Takeda Pharmaceutical's strong earnings, dividends, and strategic moves make it an appealing investment despite US policy ...
Pfizer's SWOT analysis: pharmaceutical giant faces post-covid challenges
Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies with a market capitalization of $151.25 billion, finds itself at a critical juncture as it navigates the post-pandemic ...